Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Molecular Imaging and Biology|May 17, 2024
Prostate Specific Membrane Antigen Expression in a Syngeneic Breast Cancer Mouse ModelAditi A Shirke, Jing Wang, Gopolakrishnan Ramamurthy, et al.Inorganic Chemistry|July 30, 2011
Nanoparticles of the novel coordination polymer KBi(H2O)2[Fe(CN)6]·H2O as a potential contrast agent for computed tomographyVindya S Perera, Jihua Hao, Min Gao, et al.Chemical Science|October 10, 2017
Synthesis and evaluation of MR probes for targeted-reporter imagingKirti Dhingra Verma, Justin O Massing, Sarah G Kamper, et al.Plos Computational Biology|August 2, 2008
Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancersJihua Hao, Adrian W R Serohijos, Gail Newton, et al.Nanotheranostics|February 28, 2022
Intracellular vesicle entrapment of nanobubble ultrasound contrast agents targeted to PSMA promotes prolonged enhancement and stability in vivo and in vitroReshani H Perera, Eric Abenojar, Pinunta Nittayacharn, et al.Biorxiv : the Preprint Server for Biology|September 25, 2023
Ultrasound-mediated drug-free theranostics for treatment of prostate cancerReshani Himashika Perera, Felipe Matias Berg, Eric Chua Abenojar, et al.Small (Weinheim an Der Bergstrasse, Germany)|June 2, 2011
Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?Yu Cheng, Joseph D Meyers, Richard S Agnes, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|April 30, 2020
Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubblesReshani H Perera, Al de Leon, Xinning Wang, et al.Translational Oncology|April 17, 2016
Dynamic Quantitative T1 Mapping in Orthotopic Brain Tumor XenograftsKelsey Herrmann, Bernadette O Erokwu, Mette L Johansen, et al.Theranostics|March 10, 2022
A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancerXinning Wang, Rongcan Sun, Jing Wang, et al.Pageof 8